Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities is a research paper published in Frontiers in Cell and Developmental Biology (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA210439
NCI NIH HHS
Grant: P50 CA127297
NCI NIH HHS
Grant: R01 CA163649
National Institutes of Health
Grant: 2R01CA163649-06A1
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
National Institutes of Health
Grant: 5P50CA127297-05
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma
National Institutes of Health
Grant: 3R01CA216853-03S1
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA210439-05
Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals